ACRS vs GILD: Which Stock is Better?
Side-by-side comparison of Aclaris Therapeutics Inc and Gilead Sciences Inc in 2026
ACRS
Aclaris Therapeutics Inc
$4.43
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ACRS | GILD | Winner |
|---|---|---|---|
| Market Cap | $283.86M | $154.99B | GILD |
| P/E Ratio | N/A | 19.34 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | -0.2% | 0.0% | GILD |
| Gross Margin | -275.7% | 78.7% | GILD |
Analyze ACRS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACRS or GILD a better investment?
Comparing ACRS and GILD: Aclaris Therapeutics Inc has a market cap of $283.86M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACRS and GILD?
ACRS (Aclaris Therapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACRS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACRS or GILD?
GILD has higher revenue growth at 0.0% vs -0.2% for ACRS.
Which company is more profitable: ACRS or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to -275.7% for ACRS.
Which is the larger company: ACRS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $283.86M for ACRS.
Should I buy ACRS or GILD in 2026?
Both ACRS and GILD have investment merit. ACRS trades at $4.43 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACRS and GILD stock?
Key differences: Market Cap ($283.86M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (-0.2% vs 0.0%), Gross Margin (-275.7% vs 78.7%).